Last reviewed · How we verify

NCT04555954

Determining the Physical Activity Level of Healthy Adults During Pandemic

Completed Last updated 21 September 2020
What this trial tests

trial testing surveys and questionnaires in Health, Subjective in 205 participants. Completed in 20 August 2020.

Timeline
11 April 2020
Primary endpoint
31 July 2020
20 August 2020

Quick facts

Lead sponsorPamukkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment205
Start date11 April 2020
Primary completion31 July 2020
Estimated completion20 August 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Eligibility, any sex, with Health, Subjective or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Abstract Background: With Covid-19 pandemic, online education, remote and flexible working were introduced. Thus the process of stay-at-home began. Purpose: The aim of the study is to determine level of physical activity of healthy adults in the pandemic process. Methods: This is a descriptive survey study which was applied via internet. The physical activity level was evaluated with International Physical Activity Questionnaire Short Form. Healthy adults aged 18-65 years who live in Turkey were included in the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of surveys and questionnaires

Trials testing the same drug.

Other recruiting trials for Health, Subjective

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04555954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing